Association of convalescent plasma therapy with survival in patients with blood cancers, COVID-19

(JAMA Network) What The Study Did: Researchers evaluated the association of convalescent plasma treatment with 30-day mortality in hospitalized adults with hematologic (blood) cancers and COVID-19.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news